EMILY DALTON: Open Payments
NPI 1831878362 · NEWARK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 30 payments from 10 companies in 2025. Trend: 2023 $217 · 2024 $442 · 2025 $719
Food & beverage: $496Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $304 |
| Alkermes, Inc. | 3 | $75 |
| ABBVIE INC. | 4 | $67 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 3 | $54 |
| Lundbeck LLC | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| Indivior Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: REXULTI, Auvelity, INVEGA SUSTENNA, ARISTADA, VRAYLAR, AUSTEDO XR, COBENFY, SUBLOCADE.
Industry payments across OH — which companies pay providers there.
